In last trading session, Tiziana Life Sciences Ltd (NASDAQ:TLSA) saw 0.43 million shares changing hands with its beta currently measuring 0.35. Company’s recent per share price level of $0.94 trading at -$0.08 or -7.52% at ring of the bell on the day assigns it a market valuation of $104.39M. That closing price of TLSA’s stock is at a discount of -103.19% from its 52-week high price of $1.91 and is indicating a premium of 56.38% from its 52-week low price of $0.41. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 0.35 million shares which gives us an average trading volume of 989.49K if we extend that period to 3-months.
For Tiziana Life Sciences Ltd (TLSA), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 1.00. Splitting up the data highlights that, out of 1 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 0 suggested the stock as a Hold whereas 1 see the stock as a Buy. 0 analyst(s) advised it as an Underweight.
Tiziana Life Sciences Ltd (NASDAQ:TLSA) trade information
Upright in the red during last session for losing -7.52%, in the last five days TLSA remained trading in the red while hitting it’s week-highest on Wednesday, 04/02/25 when the stock touched $0.94 price level, adding 16.81% to its value on the day. Tiziana Life Sciences Ltd’s shares saw a change of 35.49% in year-to-date performance and have moved -15.78% in past 5-day. Tiziana Life Sciences Ltd (NASDAQ:TLSA) showed a performance of -37.11% in past 30-days. Number of shares sold short was 0.81 million shares which calculate 0.57 days to cover the short interests.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of -12.98% during past 5 years.
Tiziana Life Sciences Ltd (NASDAQ:TLSA)’s Major holders
Insiders are in possession of 35.56% of company’s total shares while institution are holding 0.89 percent of that, with stock having share float percentage of 1.38%. Investors also watch the number of corporate investors in a company very closely, which is 0.89% institutions for Tiziana Life Sciences Ltd that are currently holding shares of the company. ALPHAMARK ADVISORS, LLC is the top institutional holder at TLSA for having 4589.0 shares of worth $0.31 million. And as of 2024-06-30, it was holding 0.0045 of the company’s outstanding shares.
On the other hand, Fidelity Commonwealth Trust-Fidelity Nasdaq Composite Index ETF and Fidelity Concord Street Trust-Fidelity Nasdaq Composite Index Fund are the top two Mutual Funds which own company’s shares. As of Feb 28, 2025 , the former fund manager was holding 169.35 shares of worth $0.16 million or 0.14% of the total outstanding shares. The later fund manager was in possession of 77.89 shares on Feb 28, 2025 , making its stake of worth around $73468.0 in the company or a holder of 0.07% of company’s stock.
